The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Open accessAbstract
While bile acids (BAs) have long been known to be essential in dietary lipid absorption and cholesterol catabolism, in recent years an important role for BAs as signalling molecules has emerged. BAs activate mitogen-activated protein kinase pathways, are ligands for the G-protein-coupled receptor (GPCR) TGR5 and activate nuclear hormone receptors such as farnesoid X receptor alpha (FXR-alpha; NR1H4). FXR-alpha regulates the enterohepatic recycling and biosynthesis of BAs by controlling the expression of genes such as the short heterodimer partner (SHP; NR0B2) that inhibits the activity of other nuclear receptors. The FXR-alpha-mediated SHP induction also underlies the downregulation of the hepatic fatty acid and triglyceride biosynthesis and very-low-density lipoprotein production mediated by sterol-regulatory-element-binding protein 1c. This indicates that BAs might be able to function beyond the control of BA homeostasis as general metabolic integrators. Here we show that the administration of BAs to mice increases energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This novel metabolic effect of BAs is critically dependent on induction of the cyclic-AMP-dependent thyroid hormone activating enzyme type 2 iodothyronine deiodinase (D2) because it is lost in D2-/- mice. Treatment of brown adipocytes and human skeletal myocytes with BA increases D2 activity and oxygen consumption. These effects are independent of FXR-alpha, and instead are mediated by increased cAMP production that stems from the binding of BAs with the G-protein-coupled receptor TGR5. In both rodents and humans, the most thermogenically important tissues are specifically targeted by this mechanism because they coexpress D2 and TGR5. The BA-TGR5-cAMP-D2 signalling pathway is therefore a crucial mechanism for fine-tuning energy homeostasis that can be targeted to improve metabolic control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, TGR5 has an important role in regulating energy expenditure and lipid metabolism,47”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [47]
In the citing paper
“Recently, a new role in TH-mediated thermogenesis was observed in response to bile acids 147.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [147]
In the citing paper
“It has been described that BA secretion increases energy expenditure in BAT by enhancing the enzymatic activity of DIO2 and therefore regulating thyroid hormone metabolism in BAT 97.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [97]
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Self-citationBile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21025 · Cited by 1,425
Self-citationIdentification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 714
Cited by
Sorted by citations
Items 501–600 of 1,008
Kim, T., Nason, S., Holleman, C., Pepin, M., Wilson, L., Berryhill, T. F., Wende, A. R., Steele, C., Young, M. E., Barnes, S., et al. (2018) · Diabetes · doi:10.2337/db17-1502 · Cited by 97
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
Hui, S., Liu, Y., Huang, L., Zheng, L., Zhou, M., Lang, H., Wang, X., Yi, L., & Mi, M. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0566-y · Cited by 97
Bile Acid Sequestrants for Lipid and Glucose Control
Staels, B., Handelsman, Y., & Fonseca, V. A. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0087-5 · Cited by 97
Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice
Selwyn, F. P., Csanaky, I. L., Zhang, Y., & Klaassen, C. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065276 · Cited by 97
Ziętak, M., & Kozak, L. P. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00485.2015 · Cited by 97
The Deiodinase Trio and Thyroid Hormone Signaling
Bianco, A. C., & da Conceição, R. R. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7902-8_8 · Cited by 96
Self-citationAmigo, L., Husche, C., Zanlungo, S., Lütjohann, D., Arrese, M. A., Miquel, J. F., Rigotti, A., & Nervi, F. O. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02361.x · Cited by 96
Type 2 deiodinase at the crossroads of thyroid hormone action
Drigo, R. A. E., & Bianco, A. C. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.016 · Cited by 96
Self-citationD’Amore, C., Leva, F. S. D., Sepe, V., Renga, B., Gaudio, C. D., D’Auria, M. V., Zampella, A., Fiorucci, S., & Limongelli, V. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401873d · Cited by 96
Guo, C., Qi, H., Yu, Y., Zhang, Q., Su, J., Yu, D., Huang, W., Chen, W.-D., & Wang, Y.-D. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00287 · Cited by 95
Dutia, R., Embrey, M., O'Brien, S. A., Haeusler, R. A., Agenor, K., Homel, P., McGinty, J., Vincent, R. P., Alaghband-Zadeh, J., Staels, B., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.1 · Cited by 95
Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans
Yoneshiro, T., & Saito, M. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.911595 · Cited by 94
Nakatani, A., Li, X., Miyamoto, J., Igarashi, M., Watanabe, H., Sutou, A., Watanabe, K., Motoyama, T., Tachibana, N., Kohno, M., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.090 · Cited by 95
TGR5 Signaling in Hepatic Metabolic Health
Holter, M. M., Chirikjian, M. K., Govani, V. N., & Cummings, B. P. (2020) · Nutrients · doi:10.3390/nu12092598 · Cited by 94
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 98
Expression of bile acid receptor TGR5 in gastric adenocarcinoma
Cao, W., Tian, W., Hong, J., Li, D., Tavares, R., Noble, L. C., Moss, S. F., & Resnick, M. B. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2012 · Cited by 94
The gut microbiota as a mediator of metabolic benefits after bariatric surgery
Anhê, F. F., Varin, T. V., Schertzer, J. D., & Marette, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.02.002 · Cited by 93
Farnesoid X receptor modulators 2014-present: a patent review
Sepe, V., Distrutti, E., Fiorucci, S., & Zampella, A. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1459569 · Cited by 93
de Sire, R., Rizzatti, G., Ingravalle, F., Pizzoferrato, M., Petito, V., Lopetuso, L. R., Graziani, C., Alessandro de, S. I. R. E., Mentella, M. C., Mele, M. C., et al. (2018) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.18.02511-4 · Cited by 93
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 92
Curcumin and Weight Loss: Does It Work?
Kasprzak‐Drozd, K., Oniszczuk, T., Gancarz, M., Kondracka, A., Rusinek, R., & Oniszczuk, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020639 · Cited by 93
Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
Yeom, E., & Yu, K. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00752-w · Cited by 93
Ullmer, C., Alvarez Sanchez, R., Sprecher, U., Raab, S., Mattei, P., Dehmlow, H., Sewing, S., Iglesias, A., Beauchamp, J., & Conde‐Knape, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12158 · Cited by 92
Bile Acid Receptors and Liver Cancer
Wang, X., Fu, X., Ness, C. V., Meng, Z., Ma, X., & Huang, W. (2012) · Current Pathobiology Reports · doi:10.1007/s40139-012-0003-6 · Cited by 92
Cummings, B. P., Bettaieb, A., Graham, J. L., Stanhope, K. L., Kowala, M. C., Haj, F. G., Chouinard, M. L., & Havel, P. J. (2012) · Endocrinology · doi:10.1210/en.2012-1131 · Cited by 92
Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer
Sinclair, P., Brennan, D. J., & le Roux, C. W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0057-y · Cited by 91
Jensen, D. D., Godfrey, C. B., Niklas, C., Canals, M., Kočan, M., Poole, D. P., Murphy, J. E., Alemi, F., Cottrell, G. S., Korbmacher, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455774 · Cited by 91
Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
Alam, M., Ali, S., Ahmed, S., Elasbali, A. M., Adnan, M., Islam, A., Hassan, M. I., & Yadav, D. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212162 · Cited by 91
Suzuki, T., Oba, K., Igari, Y., Matsumura, N., Watanabe, K., Futami‐Suda, S., Yasuoka, H., Ouchi, M., Suzuki, K., Kigawa, Y., et al. (2007) · Journal of Nippon Medical School · doi:10.1272/jnms.74.338 · Cited by 91
Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor
Rose, A. J., Díaz, M. B., Reimann, A., Klement, J., Walcher, T., Krones, A., Strobel, O., Werner, J. M., Peters, A., Kleyman, A., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.010 · Cited by 91
Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?
Morán‐Ramos, S., López-Contreras, B. E., & Canizales‐Quinteros, S. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.003 · Cited by 91
Chen, Y., Le, T. H., Du, Q., Zhao, Z., Liu, Y., Zou, J., Hua, W., Liu, C., & Zhu, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.021 · Cited by 90
Bile Acids, Their Receptors, and the Gut Microbiota
Poland, J. C., & Flynn, C. R. (2021) · Physiology · doi:10.1152/physiol.00028.2020 · Cited by 93
Martin, F., Wang, Y., Sprenger, N., Yap, I. K. S., Rezzi, S., Ramadan, Z., Peré‐Trepat, E., Rochat, F., Cherbut, C., van Bladeren, P., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.40 · Cited by 90
Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
Duan, H., Ning, M., Zou, Q., Ye, Y., Feng, Y., Zhang, L., Leng, Y., & Shen, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500829b · Cited by 90
Ábrigo, J., González, F., Aguirre, F. S., Tacchi, F., González, A., Meza, M. P., Simón, F., Cabrera, D., Arrese, M. A., Karpen, S. J., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29839 · Cited by 89
Vassileva, G., Hu, W., Hoos, L. M., Tetzloff, G. G., Yang, S., Liu, L., Kang, L., Davis, H. R., Hedrick, J. A., Hong, L., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0009 · Cited by 89
Sepe, V., Renga, B., Festa, C., D’Amore, C., Masullo, D., Cipriani, S., Leva, F. S. D., Monti, M. C., Novellino, E., Limongelli, V., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500889f · Cited by 89
Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms
Manning, S., Pucci, A. B. F., & Batterham, R. L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76305 · Cited by 89
Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)
Yoo, J. Y., Sniffen, S. E., Percy, K. C. M., Chidipi, B., & Pallaval, V. B. (2022) · Microorganisms · doi:10.3390/microorganisms10010108 · Cited by 88
Recent advances on FXR-targeting therapeutics
Panzitt, K., Zollner, G., Marschall, H., & Wagner, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111678 · Cited by 88
Martoni, C. J., Labbé, A., Ganopolsky, J. G., Prakash, S., & Jones, M. L. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1005474 · Cited by 87
Duan, H., Ning, M., Chen, X., Zou, Q., Zhang, L., Feng, Y., Zhang, L., Leng, Y., & Shen, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301071h · Cited by 87
Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity
Gineste, R., Sirvent, A., Paumelle, R., Helleboid, S., Aquilina, A., Darteil, R., Hum, D. W., Fruchart, J., & Staels, B. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0092 · Cited by 87
Obesity and related risk factors in gastric cardia adenocarcinoma
Olefson, S., & Moss, S. F. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0425-4 · Cited by 87
Impacts of the Human Gut Microbiome on Therapeutics
Vázquez‐Baeza, Y., Callewaert, C., Debelius, J. W., Hyde, E. R., Marotz, C. A., Morton, J. T., Swafford, A. D.-E., Vrbanac, A. F., Dorrestein, P. C., & Knight, R. D. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-042017-031849 · Cited by 87
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 89
Is there a role for thyroid hormone on spermatogenesis?
Wagner, M. S., Wajner, S. M., & Maia, A. L. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20759 · Cited by 86
Stepanov, V., Stankov, K., & Mikov, M. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.802805 · Cited by 85
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
A Metabolomics-driven Elucidation of the Anti-obesity Mechanisms of Xanthohumol
Kirkwood, J. S., Legette, L. L., Miranda, C. L., Jiang, Y., & Stevens, J. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445452 · Cited by 85
Obesity surgery and gut–brain communication
Berthoud, H., Shin, A. C., & Zheng, H. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.01.023 · Cited by 85
Out, C., Groen, A. K., & Brufau, G. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834f0ef3 · Cited by 85
The interrelationship between bile acid and vitamin A homeostasis
Saeed, A., Hoekstra, M., Hoeke, M. O., Heegsma, J., & Faber, K. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.007 · Cited by 85
Xu, J., Xie, S., Chi, S., Zhang, S., Cao, J., & Tan, B. (2022) · Food & Function · doi:10.1039/d1fo04085e · Cited by 84
The E3 Ubiquitin Ligase TEB4 Mediates Degradation of Type 2 Iodothyronine Deiodinase
Zavacki, A. M., Drigo, R. A. E., Freitas, B. C. G., Chung, M., Harney, J. W., Egri, P., Wittmann, G., Fekete, C., Gereben, B., & Bianco, A. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01498-08 · Cited by 84
Self-citationGPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
Lou, G., Ma, X., Fu, X., Meng, Z., Zhang, W., Wang, Y., Ness, C. V., Yu, D. D., Xu, R., & Huang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093567 · Cited by 84
Liver X Receptor α and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1
zu Schwabedissen, H. E. M., Böttcher, K., Chaudhry, A. S., Kroemer, H. K., Schuetz, E. G., & Kim, R. B. (2010) · Hepatology · doi:10.1002/hep.23876 · Cited by 84
New perspectives for the treatment of cholestasis: Lessons from basic science applied clinically
Boyer, J. L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.12.001 · Cited by 84
Role of Cholesterol Pathways in Norovirus Replication
Chang, K. (2009) · Journal of Virology · doi:10.1128/jvi.00005-09 · Cited by 83
Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice
Pierre, J. F., Martinez, K., Ye, H., Nadimpalli, A., Morton, T. C., Yang, J., Wang, Q., Patno, N., Chang, E. B., & Yin, D. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00202.2016 · Cited by 83
Dietary (Poly)phenols, Brown Adipose Tissue Activation, and Energy Expenditure: A Narrative Review
Mele, L., Bidault, G., Mena, P. R., Crozier, A., Brighenti, F., Vidal‐Puig, A., & Rio, D. D. (2017) · Advances in Nutrition · doi:10.3945/an.117.015792 · Cited by 83
Kim, H., & Fang, S. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.140 · Cited by 83
Leveraging the Gut to Treat Metabolic Disease
Gimeno, R. E., Briere, D. A., & Seeley, R. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.014 · Cited by 84
Intestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 83
Radun, R., & Trauner, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731707 · Cited by 83
John, C., Werner, P., Worthmann, A., Wegner, K., Tödter, K., Scheja, L., Rohn, S., Heeren, J., & Fischer, M. J. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.10.064 · Cited by 83
Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome
Poekes, L., Lanthier, N., & Leclercq, I. A. (2015) · Clinical Science · doi:10.1042/cs20150339 · Cited by 83
Bile Acid Uptake Transporters as Targets for Therapy
Slijepcevic, D., & van de Graaf, S. F. J. (2017) · Digestive Diseases · doi:10.1159/000450983 · Cited by 83
Regulation of Adaptive Thermogenesis and Browning by Prebiotics and Postbiotics
Reynés, B., Palou, M., Rodríguez, A. M., & Palou, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01908 · Cited by 83
The significance of beige and brown fat in humans
Kiefer, F. W. (2017) · Endocrine Connections · doi:10.1530/ec-17-0037 · Cited by 82
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
Mori, H., Svegliati‐Baroni, G., Marzioni, M., Nicola, F. D., Santori, P., Maroni, L., Abenavoli, L., & Scarpellini, E. (2022) · Metabolites · doi:10.3390/metabo12070647 · Cited by 82
Dissecting the role of insulin resistance in the metabolic syndrome
Haas, J. T., & Biddinger, S. B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b2024 · Cited by 82
Bile acid receptors and nonalcoholic fatty liver disease
Yuan, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2811 · Cited by 82
The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABAA receptors
Schubring, S. R., Fleischer, W., Lin, J. S., Haas, H. L., & Sergeeva, O. A. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.036 · Cited by 81
Current and Future Drug Targets in Weight Management
Witkamp, R. F. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0341-1 · Cited by 81
Chang, S., Kim, Y.-H., Kim, Y.-J., Kim, Y., Moon, S., Lee, Y. Y., Jung, J. S., Kim, Y., Jung, H.-E., Kim, T.-J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01984 · Cited by 81
An Integrated Approach to Skeletal Muscle Health in Aging
Agostini, D., Gervasi, M., Ferrini, F., Bartolacci, A., Stranieri, A., Piccoli, G., Barbieri, E., Sestili, P., Patti, A., Stocchi, V., et al. (2023) · Nutrients · doi:10.3390/nu15081802 · Cited by 81
Schmidt, J. B., Pedersen, S. D., Gregersen, N. T., Vestergaard, L., Nielsen, M. S., Ritz, C., Madsbad, S., Worm, D., Hansen, D. L., Clausen, T. R., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.162 · Cited by 81
Role of bile acids in the regulation of the metabolic pathways
Taoka, H., Yokoyama, Y., Morimoto, K., Kitamura, N., Tanigaki, T., Takashina, Y., Tsubota, K., & Watanabe, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i13.260 · Cited by 80
Briere, D. A., Ruan, X., Cheng, C., Siesky, A. M., Fitch, T. E., Dominguez, C., Sanfeliciano, S. G., Montero, C., Suen, C. S., Xu, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136873 · Cited by 80
Glucose stimulates cholesterol 7α-hydroxylase gene transcription in human hepatocytes
Li, T., Chanda, D., Zhang, Y., Choi, H., & Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002782 · Cited by 80
Role of Bile Acids in Bariatric Surgery
Wang, W., Cheng, Z., Wang, Y., Dai, Y., Zhang, X., & Hu, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00374 · Cited by 80
Ietswaart, R., Arat, S., Chen, A. X., Farahmand, S., Kim, B., DuMouchel, W., Armstrong, D., Fekete, A., Sutherland, J. J., & Urbán, L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102837 · Cited by 80
Self-citationMolecular Regulation of Bile Acid Homeostasis
Choudhuri, S., & Klaassen, C. D. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000643 · Cited by 79
Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 79
Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice
Uebi, T., Itoh, Y., Hatano, O., Kumagai, A., Sanosaka, M., Sasaki, T., Sasagawa, S., Doi, J., Tatsumi, K., Mitamura, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037803 · Cited by 79
Specific bile acids inhibit hepatic fatty acid uptake in mice
Nie, B., Park, H. M., Kazantzis, M., Lin, M., Henkin, A. H., Ng, S. M., Song, S., Chen, Y., Tran, H., Lai, R., et al. (2012) · Hepatology · doi:10.1002/hep.25797 · Cited by 79
Zhu, Y., Zhang, J., Wei, Y., Hao, J., Lei, Y., Zhao, W., Xiao, Y., & Sun, A. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00473-9 · Cited by 78
Jin, P., Deng, S., Tian, M., Lenahan, C., Wei, P., Wang, Y., Tan, J., Wen, H., Zhao, F., Gao, Y., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113504 · Cited by 79
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Samarraie, A. A., Pichette, M., & Rousseau, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065420 · Cited by 78
Hodge, R. J., Lin, J., Johnson, L. S. V., Gould, E. P., Bowers, G. D., Nunez, D. J., & on behalf of the SB‐756050 Project Team (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.34 · Cited by 78
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M. (2008) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78
Enhancement of brown fat thermogenesis using chenodeoxycholic acid in mice
Teodoro, J. S., Zouhar, P., Flachs, P., Bardová, K., Janovská, P., Gomes, A. P., Duarte, F. V., Varela, A. T. I. F., Rolo, A. P., Palmeira, C. M., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.230 · Cited by 78
Detection technologies and metabolic profiling of bile acids: a comprehensive review
Liu, Y., Rong, Z., Xiang, D., Zhang, C., & Liu, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0774-9 · Cited by 78
Choucair, I., Nemet, I., Li, L., Cole, M. A., Skye, S. M., Kirsop, J. D., Fischbach, M. A., Gogonea, V., Brown, J. M., Tang, W. H. W., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000311 · Cited by 77
Bjursell, M., Wedin, M., Admyre, T., Hermansson, M., Böttcher, G., Göransson, M., Lindén, D., Bamberg, K., Oscarsson, J., & Bohlooly‐Y, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064721 · Cited by 77
Han, L., Fan, Y., Mu, N.-N., Gao, S., Li, F., Ji, X., Dou, C., & Wang, K. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.6745 · Cited by 77
Kobori, M., Ni, Y., Takahashi, Y., Watanabe, N., Sugiura, M., Ogawa, K., Nagashimada, M., Kaneko, S., Naito, S., & Ota, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098294 · Cited by 77
Metadata
- Authors
- Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., Schoonjans, K., Bianco, A. C., & Auwerx, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Brigham and Women's Hospital (US)
- National Institute of Health and Nutrition (JP)
- The University of Tokyo (JP)
- Corresponding author
- Auwerx, Johan
- ORCID
- Venue
- Nature
- Published
- 2006-01
- Volume
- 439
- Issue
- 7075
- Pages
- 484-489
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081028309
- Cited by
- 2,220
- References
- 26
- Citations by year
- 2026: 108 · 2025: 112 · 2024: 118 · 2023: 121 · 2022: 140 · 2021: 150 · 2020: 135 · 2019: 128 · 2018: 132 · 2017: 144 · 2016: 126 · 2015: 131 · 2014: 101 · 2013: 102 · 2012: 87
- FWCI
- 47.28
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Centre National de la Recherche Scientifique
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- bile acids, energy expenditure, thyroid hormone activation, TGR5, cAMP signaling, brown adipose tissue, thermogenesis, obesity, insulin resistance, enterohepatic circulation, metabolic homeostasis
- MeSH terms
- Iodothyronine Deiodinase Type II, Cyclic AMP, Animals, Bile Acids and Salts, Body Weight, Adipose Tissue, Brown, Carbon Dioxide, Dietary Fats, Energy Metabolism, Homeostasis, Humans, Iodide Peroxidase, Liver, Mice, Inbred C57BL, Oxygen Consumption, Thyroid Hormones, Gene Deletion, Muscle, Skeletal, Cholic Acid, Muscle Cells, Receptors, G-Protein-Coupled, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review